ID   LCAP_HUMAN              Reviewed;        1025 AA.
AC   Q9UIQ6; O00769; Q15145; Q59H76; Q9TNQ2; Q9TNQ3; Q9UIQ7;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 3.
DT   04-FEB-2015, entry version 148.
DE   RecName: Full=Leucyl-cystinyl aminopeptidase;
DE            Short=Cystinyl aminopeptidase;
DE            EC=3.4.11.3;
DE   AltName: Full=Insulin-regulated membrane aminopeptidase;
DE   AltName: Full=Insulin-responsive aminopeptidase;
DE            Short=IRAP;
DE   AltName: Full=Oxytocinase;
DE            Short=OTase;
DE   AltName: Full=Placental leucine aminopeptidase;
DE            Short=P-LAP;
DE   Contains:
DE     RecName: Full=Leucyl-cystinyl aminopeptidase, pregnancy serum form;
GN   Name=LNPEP; Synonyms=OTASE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 160-168; 319-332;
RP   615-624; 635-647; 798-814 AND 870-880, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=8550619; DOI=10.1074/jbc.271.1.56;
RA   Rogi T., Tsujimoto M., Nakazato H., Mizutani S., Tomoda Y.;
RT   "Human placental leucine aminopeptidase/oxytocinase. A new member of
RT   type II membrane-spanning zinc metallopeptidase family.";
RL   J. Biol. Chem. 271:56-61(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=9177475; DOI=10.1016/S0167-4781(97)00036-5;
RA   Laustsen P.G., Rasmussen T.E., Petersen K., Pedraza-Diaz S.,
RA   Moestrup S.K., Gliemann J., Sottrup-Jensen L., Kristensen T.;
RT   "The complete amino acid sequence of human placental oxytocinase.";
RL   Biochim. Biophys. Acta 1352:1-7(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 3).
RX   PubMed=10759854; DOI=10.1046/j.1432-1327.2000.01234.x;
RA   Rasmussen T.E., Pedraza-Diaz S., Hardre R., Laustsen P.G.,
RA   Carrion A.G., Kristensen T.;
RT   "Structure of the human oxytocinase/insulin-regulated aminopeptidase
RT   gene and localization to chromosome 5q21.";
RL   Eur. J. Biochem. 267:2297-2306(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), FUNCTION, CATALYTIC
RP   ACTIVITY, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11389728; DOI=10.1046/j.1432-1327.2001.02221.x;
RA   Matsumoto H., Nagasaka T., Hattori A., Rogi T., Tsuruoka N.,
RA   Mizutani S., Tsujimoto M.;
RT   "Expression of placental leucine aminopeptidase/oxytocinase in
RT   neuronal cells and its action on neuronal peptides.";
RL   Eur. J. Biochem. 268:3259-3266(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 206-1025.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PROTEIN SEQUENCE OF 285-301 AND 710-724.
RX   PubMed=8119729; DOI=10.1007/BF00188785;
RA   Falk K., Roetzschke O., Stevanovic S., Jung G., Rammensee H.G.;
RT   "Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals
RT   detailed peptide motifs, constraints of processing, and general
RT   rules.";
RL   Immunogenetics 39:230-242(1994).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=1731608; DOI=10.1016/0003-9861(92)90007-J;
RA   Tsujimoto M., Mizutani S., Adachi H., Kimura M., Nakazato H.,
RA   Tomoda Y.;
RT   "Identification of human placental leucine aminopeptidase as
RT   oxytocinase.";
RL   Arch. Biochem. Biophys. 292:388-392(1992).
RN   [8]
RP   FUNCTION.
RX   PubMed=11707427; DOI=10.1074/jbc.C100512200;
RA   Albiston A.L., McDowall S.G., Matsacos D., Sim P., Clune E.,
RA   Mustafa T., Lee J., Mendelsohn F.A., Simpson R.J., Connolly L.M.,
RA   Chai S.Y.;
RT   "Evidence that the angiotensin IV (AT(4)) receptor is the enzyme
RT   insulin-regulated aminopeptidase.";
RL   J. Biol. Chem. 276:48623-48626(2001).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-184; ASN-448; ASN-682 AND
RP   ASN-850.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Release of an N-terminal amino acid, cleaves before
CC       cysteine, leucine as well as other amino acids. Degrades peptide
CC       hormones such as oxytocin, vasopressin and angiotensin III, and
CC       plays a role in maintaining homeostasis during pregnancy. May be
CC       involved in the inactivation of neuronal peptides in the brain.
CC       Cleaves Met-enkephalin and dynorphin. Binds angiotensin IV and may
CC       be the angiotensin IV receptor in the brain.
CC       {ECO:0000269|PubMed:11389728, ECO:0000269|PubMed:11707427,
CC       ECO:0000269|PubMed:1731608}.
CC   -!- CATALYTIC ACTIVITY: Release of an N-terminal amino acid, Cys-|-
CC       Xaa-, in which the half-cystine residue is involved in a disulfide
CC       loop, notably in oxytocin or vasopressin. Hydrolysis rates on a
CC       range of aminoacyl arylamides exceed that for the cystinyl
CC       derivative, however. {ECO:0000269|PubMed:11389728,
CC       ECO:0000269|PubMed:1731608}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Homodimer. Binds tankyrases 1 and 2.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11389728};
CC       Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:11389728}. Note=In brain only the membrane-
CC       bound form is found. The protein resides in intracellular vesicles
CC       together with GLUT4 and can then translocate to the cell surface
CC       in response to insulin and/or oxytocin. Localization may be
CC       determined by dileucine internalization motifs, and/or by
CC       interaction with tankyrases.
CC   -!- SUBCELLULAR LOCATION: Leucyl-cystinyl aminopeptidase, pregnancy
CC       serum form: Secreted. Note=During pregnancy serum levels are low
CC       in the first trimester, rise progressively during the second and
CC       third trimester and decrease rapidly after parturition.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=1;
CC         IsoId=Q9UIQ6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UIQ6-2; Sequence=VSP_005448;
CC       Name=3;
CC         IsoId=Q9UIQ6-3; Sequence=VSP_005449;
CC   -!- TISSUE SPECIFICITY: Highly expressed in placenta, heart, kidney
CC       and small intestine. Detected at lower levels in neuronal cells in
CC       the brain, in skeletal muscle, spleen, liver, testes and colon.
CC       {ECO:0000269|PubMed:11389728, ECO:0000269|PubMed:8550619,
CC       ECO:0000269|PubMed:9177475}.
CC   -!- PTM: The pregnancy serum form is derived from the membrane-bound
CC       form by proteolytic processing.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:19349973}.
CC   -!- SIMILARITY: Belongs to the peptidase M1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA09436.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAD92120.1; Type=Frameshift; Positions=405; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D50810; BAA09436.1; ALT_INIT; mRNA.
DR   EMBL; U62768; AAB66672.1; -; mRNA.
DR   EMBL; U62769; AAB66673.1; -; mRNA.
DR   EMBL; AJ131023; CAB61646.1; -; Genomic_DNA.
DR   EMBL; AJ131025; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131026; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131027; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131028; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131029; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131030; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131031; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131032; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131033; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131034; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131035; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131036; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131037; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131038; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131039; CAB61646.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131025; CAB94753.1; -; Genomic_DNA.
DR   EMBL; AJ131026; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131027; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131028; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131029; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131030; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131031; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131032; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131033; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131034; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131035; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131036; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131037; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131038; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131039; CAB94753.1; JOINED; Genomic_DNA.
DR   EMBL; AB208883; BAD92120.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS4087.1; -. [Q9UIQ6-1]
DR   CCDS; CCDS43346.1; -. [Q9UIQ6-2]
DR   PIR; A59383; A59383.
DR   PIR; A59384; A59384.
DR   RefSeq; NP_005566.2; NM_005575.2. [Q9UIQ6-1]
DR   RefSeq; NP_787116.2; NM_175920.3. [Q9UIQ6-2]
DR   UniGene; Hs.527199; -.
DR   UniGene; Hs.656905; -.
DR   PDB; 4P8Q; X-ray; 3.02 A; A/B=155-1025.
DR   PDB; 4PJ6; X-ray; 2.96 A; A/B=155-1025.
DR   PDBsum; 4P8Q; -.
DR   PDBsum; 4PJ6; -.
DR   ProteinModelPortal; Q9UIQ6; -.
DR   SMR; Q9UIQ6; 161-1025.
DR   BioGrid; 110196; 20.
DR   IntAct; Q9UIQ6; 4.
DR   STRING; 9606.ENSP00000231368; -.
DR   BindingDB; Q9UIQ6; -.
DR   ChEMBL; CHEMBL2693; -.
DR   MEROPS; M01.011; -.
DR   PhosphoSite; Q9UIQ6; -.
DR   DMDM; 145559489; -.
DR   MaxQB; Q9UIQ6; -.
DR   PaxDb; Q9UIQ6; -.
DR   PeptideAtlas; Q9UIQ6; -.
DR   PRIDE; Q9UIQ6; -.
DR   DNASU; 4012; -.
DR   Ensembl; ENST00000231368; ENSP00000231368; ENSG00000113441. [Q9UIQ6-1]
DR   Ensembl; ENST00000395770; ENSP00000379117; ENSG00000113441. [Q9UIQ6-2]
DR   GeneID; 4012; -.
DR   KEGG; hsa:4012; -.
DR   UCSC; uc003kmv.1; human. [Q9UIQ6-1]
DR   CTD; 4012; -.
DR   GeneCards; GC05P096272; -.
DR   H-InvDB; HIX0005054; -.
DR   HGNC; HGNC:6656; LNPEP.
DR   HPA; HPA043642; -.
DR   MIM; 151300; gene.
DR   neXtProt; NX_Q9UIQ6; -.
DR   PharmGKB; PA30418; -.
DR   eggNOG; COG0308; -.
DR   GeneTree; ENSGT00760000119082; -.
DR   HOVERGEN; HBG108296; -.
DR   InParanoid; Q9UIQ6; -.
DR   KO; K01257; -.
DR   OMA; TEEVQWI; -.
DR   OrthoDB; EOG754HNR; -.
DR   PhylomeDB; Q9UIQ6; -.
DR   TreeFam; TF300395; -.
DR   Reactome; REACT_111168; Endosomal/Vacuolar pathway.
DR   Reactome; REACT_147867; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; REACT_75842; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SABIO-RK; Q9UIQ6; -.
DR   ChiTaRS; LNPEP; human.
DR   GeneWiki; Cystinyl_aminopeptidase; -.
DR   GenomeRNAi; 4012; -.
DR   NextBio; 15736; -.
DR   PMAP-CutDB; Q9UIQ6; -.
DR   PRO; PR:Q9UIQ6; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; Q9UIQ6; -.
DR   CleanEx; HS_LNPEP; -.
DR   Genevestigator; Q9UIQ6; -.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031905; C:early endosome lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005622; C:intracellular; IDA:HGNC.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:ProtInc.
DR   GO; GO:0004177; F:aminopeptidase activity; TAS:HGNC.
DR   GO; GO:0008237; F:metallopeptidase activity; TAS:ProtInc.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0007565; P:female pregnancy; TAS:ProtInc.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0030163; P:protein catabolic process; IEA:Ensembl.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   InterPro; IPR024571; ERAP1-like_C_dom.
DR   InterPro; IPR001930; Peptidase_M1.
DR   InterPro; IPR014782; Peptidase_M1_N.
DR   PANTHER; PTHR11533; PTHR11533; 1.
DR   Pfam; PF11838; ERAP1_C; 1.
DR   Pfam; PF01433; Peptidase_M1; 1.
DR   PRINTS; PR00756; ALADIPTASE.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Aminopeptidase;
KW   Cell membrane; Complete proteome; Direct protein sequencing;
KW   Glycoprotein; Hydrolase; Membrane; Metal-binding; Metalloprotease;
KW   Phosphoprotein; Polymorphism; Protease; Reference proteome; Secreted;
KW   Signal-anchor; Transmembrane; Transmembrane helix; Zinc.
FT   CHAIN         1   1025       Leucyl-cystinyl aminopeptidase.
FT                                /FTId=PRO_0000095114.
FT   CHAIN       155   1025       Leucyl-cystinyl aminopeptidase, pregnancy
FT                                serum form.
FT                                /FTId=PRO_0000292264.
FT   TOPO_DOM      1    110       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    111    131       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM    132   1025       Extracellular. {ECO:0000255}.
FT   REGION       96    101       Tankyrase binding.
FT   REGION      428    432       Substrate binding. {ECO:0000250}.
FT   MOTIF        53     54       Dileucine internalization motif.
FT                                {ECO:0000255}.
FT   MOTIF        76     77       Dileucine internalization motif.
FT                                {ECO:0000255}.
FT   ACT_SITE    465    465       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095}.
FT   METAL       464    464       Zinc; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095}.
FT   METAL       468    468       Zinc; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095}.
FT   METAL       487    487       Zinc; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10095}.
FT   BINDING     295    295       Substrate. {ECO:0000250}.
FT   SITE        154    155       Cleavage; to produce pregnancy serum
FT                                form.
FT   SITE        549    549       Transition state stabilizer.
FT                                {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000269|PubMed:22814378}.
FT   MOD_RES      70     70       Phosphotyrosine. {ECO:0000250}.
FT   MOD_RES      80     80       Phosphoserine. {ECO:0000250}.
FT   MOD_RES      91     91       Phosphoserine. {ECO:0000250}.
FT   CARBOHYD    145    145       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    215    215       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    256    256       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    266    266       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    368    368       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    374    374       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    448    448       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    525    525       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    578    578       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    598    598       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    664    664       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    682    682       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    760    760       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    834    834       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    850    850       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    989    989       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ       1     19       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11389728}.
FT                                /FTId=VSP_005449.
FT   VAR_SEQ       1     14       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11389728,
FT                                ECO:0000303|PubMed:9177475}.
FT                                /FTId=VSP_005448.
FT   VARIANT      86     86       S -> P (in dbSNP:rs3797799).
FT                                /FTId=VAR_031616.
FT   VARIANT     594    594       N -> I (in dbSNP:rs12520455).
FT                                /FTId=VAR_051567.
FT   VARIANT     763    763       A -> T (in dbSNP:rs2303138).
FT                                /FTId=VAR_012812.
FT   VARIANT     913    913       S -> T (in dbSNP:rs17087233).
FT                                /FTId=VAR_051568.
FT   VARIANT     963    963       I -> V (in dbSNP:rs11746232).
FT                                /FTId=VAR_031617.
FT   CONFLICT     66     66       D -> V (in Ref. 3; CAB61646/CAB94753).
FT                                {ECO:0000305}.
FT   CONFLICT    301    301       S -> L (in Ref. 6; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    386    386       K -> N (in Ref. 2; AAB66672/AAB66673 and
FT                                3; CAB61646/CAB94753). {ECO:0000305}.
FT   CONFLICT    892    892       K -> Q (in Ref. 1; BAA09436).
FT                                {ECO:0000305}.
FT   CONFLICT    944    944       F -> L (in Ref. 1; BAA09436).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1025 AA;  117349 MW;  F84C0EA9D48DC2C0 CRC64;
     MEPFTNDRLQ LPRNMIENSM FEEEPDVVDL AKEPCLHPLE PDEVEYEPRG SRLLVRGLGE
     HEMEEDEEDY ESSAKLLGMS FMNRSSGLRN SATGYRQSPD GACSVPSART MVVCAFVIVV
     AVSVIMVIYL LPRCTFTKEG CHKKNQSIGL IQPFATNGKL FPWAQIRLPT AVVPLRYELS
     LHPNLTSMTF RGSVTISVQA LQVTWNIILH STGHNISRVT FMSAVSSQEK QAEILEYAYH
     GQIAIVAPEA LLAGHNYTLK IEYSANISSS YYGFYGFSYT DESNEKKYFA ATQFEPLAAR
     SAFPCFDEPA FKATFIIKII RDEQYTALSN MPKKSSVVLD DGLVQDEFSE SVKMSTYLVA
     FIVGEMKNLS QDVNGTLVSI YAVPEKIGQV HYALETTVKL LEFFQNYFEI QYPLKKLDLV
     AIPDFEAGAM ENWGLLTFRE ETLLYDSNTS SMADRKLVTK IIAHELAHQW FGNLVTMKWW
     NDLWLNEGFA TFMEYFSLEK IFKELSSYED FLDARFKTMK KDSLNSSHPI SSSVQSSEQI
     EEMFDSLSYF KGSSLLLMLK TYLSEDVFQH AVVLYLHNHS YASIQSDDLW DSFNEVTNQT
     LDVKRMMKTW TLQKGFPLVT VQKKGKELFI QQERFFLNMK PEIQPSDTSY LWHIPLSYVT
     EGRNYSKYQS VSLLDKKSGV INLTEEVLWV KVNINMNGYY IVHYADDDWE ALIHQLKINP
     YVLSDKDRAN LINNIFELAG LGKVPLKRAF DLINYLGNEN HTAPITEALF QTDLIYNLLE
     KLGYMDLASR LVTRVFKLLQ NQIQQQTWTD EGTPSMRELR SALLEFACTH NLGNCSTTAM
     KLFDDWMASN GTQSLPTDVM TTVFKVGAKT DKGWSFLLGK YISIGSEAEK NKILEALASS
     EDVRKLYWLM KSSLNGDNFR TQKLSFIIRT VGRHFPGHLL AWDFVKENWN KLVQKFPLGS
     YTIQNIVAGS TYLFSTKTHL SEVQAFFENQ SEATFRLRCV QEALEVIQLN IQWMEKNLKS
     LTWWL
//
